Literature DB >> 18671280

Breakpoint localization using array-CGH in three siblings with an unbalanced 4q;16q translocation and childhood apraxia of speech (CAS).

Lawrence D Shriberg1, Kathy J Jakielski, Hatem El-Shanti.   

Abstract

We report clinical, cytogenetic, and comparative genomic hybridization findings for three siblings with an unbalanced 4q;16q translocation, minor malformations, and cognitive abnormalities, including childhood apraxia of speech, a rare, severe motor speech disorder. Breakpoint findings indicate that in addition to possible contributions from duplicated genes on chromosome 16, haploinsufficiency of one or more of 11 genes deleted in the telomeric region of the long arm of chromosome 4 is the likely cause of the speech disorder, the associated impairments in cognition and language, and the dysmorphic features. The present findings are the first to document childhood apraxia of speech in a multiplex family using contemporary speech measures. We suggest that genotype-phenotype studies of childhood apraxia of speech occurring in complex neurodevelopmental disorders can elucidate the pathophysiology of this disorder. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18671280     DOI: 10.1002/ajmg.a.32363

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  12 in total

1.  The hypothesis of apraxia of speech in children with autism spectrum disorder.

Authors:  Lawrence D Shriberg; Rhea Paul; Lois M Black; Jan P van Santen
Journal:  J Autism Dev Disord       Date:  2011-04

2.  A nonword repetition task for speakers with misarticulations: the Syllable Repetition Task (SRT).

Authors:  Lawrence D Shriberg; Heather L Lohmeier; Thomas F Campbell; Christine A Dollaghan; Jordan R Green; Christopher A Moore
Journal:  J Speech Lang Hear Res       Date:  2009-07-27       Impact factor: 2.297

3.  Phenotype of FOXP2 haploinsufficiency in a mother and son.

Authors:  Gregory M Rice; Gordana Raca; Kathy J Jakielski; Jennifer J Laffin; Christina M Iyama-Kurtycz; Sigan L Hartley; Rae E Sprague; Anne T Heintzelman; Lawrence D Shriberg
Journal:  Am J Med Genet A       Date:  2011-11-21       Impact factor: 2.802

4.  Prevalence and phenotype of childhood apraxia of speech in youth with galactosemia.

Authors:  Lawrence D Shriberg; Nancy L Potter; Edythe A Strand
Journal:  J Speech Lang Hear Res       Date:  2010-10-21       Impact factor: 2.297

Review 5.  Insights into the genetic foundations of human communication.

Authors:  Sarah A Graham; Pelagia Deriziotis; Simon E Fisher
Journal:  Neuropsychol Rev       Date:  2015-01-18       Impact factor: 7.444

6.  Encoding, memory, and transcoding deficits in Childhood Apraxia of Speech.

Authors:  Lawrence D Shriberg; Heather L Lohmeier; Edythe A Strand; Kathy J Jakielski
Journal:  Clin Linguist Phon       Date:  2012-05       Impact factor: 1.346

7.  A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: II. Validity Studies of the Pause Marker.

Authors:  Lawrence D Shriberg; Edythe A Strand; Marios Fourakis; Kathy J Jakielski; Sheryl D Hall; Heather B Karlsson; Heather L Mabie; Jane L McSweeny; Christie M Tilkens; David L Wilson
Journal:  J Speech Lang Hear Res       Date:  2017-04-14       Impact factor: 2.297

8.  Estimates of the prevalence of speech and motor speech disorders in persons with complex neurodevelopmental disorders.

Authors:  Lawrence D Shriberg; Edythe A Strand; Kathy J Jakielski; Heather L Mabie
Journal:  Clin Linguist Phon       Date:  2019       Impact factor: 1.346

9.  Novel candidate genes and regions for childhood apraxia of speech identified by array comparative genomic hybridization.

Authors:  Jennifer J S Laffin; Gordana Raca; Craig A Jackson; Edythe A Strand; Kathy J Jakielski; Lawrence D Shriberg
Journal:  Genet Med       Date:  2012-07-05       Impact factor: 8.822

Review 10.  Neurogenomics of speech and language disorders: the road ahead.

Authors:  Pelagia Deriziotis; Simon E Fisher
Journal:  Genome Biol       Date:  2013-04-18       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.